{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:30:49Z","timestamp":1791862249965,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.14283\/jpad.2024.124","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T10:38:00Z","timestamp":1719311880000},"page":"831-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4"],"prefix":"10.1016","volume":"11","author":[{"given":"Doris","family":"Molina-Henry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Langford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.C.","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Rissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.14283\/jpad.2024.124_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/alz.12433","article-title":"Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria","volume":"18","author":"Franzen","year":"2022","journal-title":"Alzheimers Dement"},{"issue":"12","key":"10.14283\/jpad.2024.124_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001918","article-title":"Diversity in Clinical and Biomedical Research: A Promise Yet to Be Fulfilled","volume":"12","author":"Oh","year":"2015","journal-title":"PLoS Med"},{"issue":"2","key":"10.14283\/jpad.2024.124_bib3","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1371\/journal.pmed.0030019","article-title":"Are racial and ethnic minorities less willing to participate in health research?","volume":"3","author":"Wendler","year":"2006","journal-title":"PLoS Med"},{"issue":"1","key":"10.14283\/jpad.2024.124_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jalz.2018.06.3063","article-title":"Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (20152060) in adults aged >\/=65 years","volume":"15","author":"Matthews","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.14283\/jpad.2024.124_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","article-title":"2021 Alzheimer's disease facts and figures","volume":"17","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"11","key":"10.14283\/jpad.2024.124_bib6","doi-asserted-by":"crossref","first-page":"e1491","DOI":"10.1212\/WNL.0000000000011599","article-title":"Amyloid PET Imaging in Self-Identified Non-Hispanic Black Participants of the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) Study","volume":"96","author":"Deters","year":"2021","journal-title":"Neurology"},{"issue":"7","key":"10.14283\/jpad.2024.124_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14364","article-title":"Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial","volume":"4","author":"Raman","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.14283\/jpad.2024.124_bib8","article-title":"Eligibility Rates among Racially and Ethnically Diverse US Participants in Phase 2 and Phase 3 Placebo-Controlled, Double-Blind, Randomized Trials of Lecanemab and Elenbecestat in Early Alzheimer Disease","author":"Grill","year":"2023","journal-title":"Ann Neurol"},{"key":"10.14283\/jpad.2024.124_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/alz.13803","article-title":"Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial","author":"Molina-Henry","year":"2024","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.14283\/jpad.2024.124_bib10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1212\/WNL.0000000000001834","article-title":"Mixed pathology is more likely in black than white decedents with Alzheimer dementia","volume":"85","author":"Barnes","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.14283\/jpad.2024.124_bib11","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/alz.12754","article-title":"Using Alzheimer's disease blood tests to accelerate clinical trial enrollment","volume":"19","author":"Schindler","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2024.124_bib12","unstructured":"Raman R, Walter, S., Jimenez-Maggiora G., Rissman R., Atri A., Goldman D., Grill J., Marshal G.A., Jicha G., Racke M., Turner R., Van Dyck C., Venkatesh V., Sperling R., Aisen P. Feasibility of remote blood collection and plasma biomarker analyses to assess eligibility for Alzheimer's disease preclinical clinical trials - the Alzmatch study. presented at: Clinical trials on Alzheimer's Disease; 2023; Boston. Session Symposia LB26."},{"issue":"10","key":"10.14283\/jpad.2024.124_bib13","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1038\/s41380-020-0838-x","article-title":"Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study","volume":"26","author":"O'Connor","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"8","key":"10.14283\/jpad.2024.124_bib14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.14283\/jpad.2024.124_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s43587-023-00405-1","article-title":"Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies","volume":"3","author":"Montoliu-Gaya","year":"2023","journal-title":"Nat Aging"},{"key":"10.14283\/jpad.2024.124_bib16","author":"Jonaitis"},{"key":"10.14283\/jpad.2024.124_bib17","author":"Tissot"},{"issue":"8","key":"10.14283\/jpad.2024.124_bib18","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/alz.12301","article-title":"Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study","volume":"17","author":"Brickman","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.14283\/jpad.2024.124_bib19","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1212\/WNL.0000000000200358","article-title":"Effect of Race on Prediction of Brain Amyloidosis by Plasma Abeta42\/Abeta40, Phosphorylated Tau, and Neurofilament Light","volume":"99","author":"Schindler","year":"2022","journal-title":"Neurology"},{"key":"10.14283\/jpad.2024.124_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.871947","article-title":"Characterizing Plasma Biomarkers of Alzheimer's in a Diverse Community-Based Cohort: A Cross-Sectional Study of the HAB-HD Cohort","volume":"13","author":"Hall","year":"2022","journal-title":"Front Neurol"},{"issue":"228","key":"10.14283\/jpad.2024.124_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.14283\/jpad.2024.124_bib22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","article-title":"Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals","volume":"77","author":"Sperling","year":"2020","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.14283\/jpad.2024.124_bib23","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of Solanezumab in Preclinical Alzheimer's Disease","volume":"389","author":"Sperling","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"10.14283\/jpad.2024.124_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13195-021-00836-1","article-title":"Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach","volume":"13","author":"Royse","year":"2021","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"10.14283\/jpad.2024.124_bib25","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/pan\/mpl013","article-title":"Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference","volume":"15","author":"Ho","year":"2007","journal-title":"Political Analysis"},{"issue":"1","key":"10.14283\/jpad.2024.124_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-023-00605-8","article-title":"Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications","volume":"18","author":"Gonzalez-Ortiz","year":"2023","journal-title":"Mol Neurodegener"},{"issue":"4","key":"10.14283\/jpad.2024.124_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s43587-023-00380-7","article-title":"CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease","volume":"3","author":"Barthelemy","year":"2023","journal-title":"Nat Aging"},{"issue":"5","key":"10.14283\/jpad.2024.124_bib28","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ana.26891","article-title":"Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset","volume":"95","author":"Li","year":"2024","journal-title":"Ann Neurol"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:07:15Z","timestamp":1737338835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2274580724000050"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.124","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between Plasma P-Tau217 and Amyloid PET in Racial and Ethnic Underrepresented Groups (RE-URG) Compared with Non RE-URG in LEARN and A4","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}